Literature DB >> 21764076

Aortic implantation of mesenchymal stem cells after aneurysm injury in a porcine model.

Irene C Turnbull1, Lahouaria Hadri, Kleopatra Rapti, Mikel Sadek, Lifan Liang, Hyun J Shin, Kevin D Costa, Michael L Marin, Roger J Hajjar, Peter L Faries.   

Abstract

BACKGROUND: Cell-based therapies are being evaluated in the setting of degenerative pathophysiologic conditions. The search for the ideal method of delivery and improvement in cell engraftment continue to pose a challenge. This study explores the feasibility of introducing mesenchymal stem cells (MSC) following aortic injury in a porcine model.
METHODS: Bone marrow-derived MSC were obtained from eight pigs, characterized for the MSC markers CD13 and CD 29, labeled with green fluorescent protein (GFP), and collected for autologous injection in a porcine model of abdominal aortic aneurysm (AAA). The pigs were euthanized (1-7 d) after the procedure to assess the histologic characteristics and presence of MSC in the aortic tissue. Negative controls included noninjured aorta. Tracking of the MSC was conducted by the identification of the GFP-labeled cells using immunofluorescence.
RESULTS: AAA sections stained with hematoxylin and eosin showed disorganization of the aortic tissue; collagen-muscle-elastin stain demonstrated fragmentation of elastin fibers. The presence of the implanted MSC in the aortic wall was evidenced by fluorescent microscopy showing GFP labeled cells. Engraftment of MSC up to 7 d after introduction was observed.
CONCLUSION: Autologous implantation of bone marrow-derived MSC following aortic injury in a porcine model may be successfully accomplished. The long-term impact and therapeutic value of such cell-based therapy will require further investigation.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21764076      PMCID: PMC3154453          DOI: 10.1016/j.jss.2011.05.042

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  38 in total

Review 1.  Mesenchymal stem cells: biology and potential clinical uses.

Authors:  R J Deans; A B Moseley
Journal:  Exp Hematol       Date:  2000-08       Impact factor: 3.084

2.  Revised Guide for the Care and Use of Laboratory Animals available. American Physiological Society.

Authors:  K Bayne
Journal:  Physiologist       Date:  1996-08

Review 3.  Mesenchymal stem cells: building blocks for molecular medicine in the 21st century.

Authors:  A I Caplan; S P Bruder
Journal:  Trends Mol Med       Date:  2001-06       Impact factor: 11.951

4.  Role of vascular endothelial growth factor-A in development of abdominal aortic aneurysm.

Authors:  Hidehiro Kaneko; Toshihisa Anzai; Toshiyuki Takahashi; Takashi Kohno; Masayuki Shimoda; Aya Sasaki; Hideyuki Shimizu; Toshiyuki Nagai; Yuichiro Maekawa; Koichi Yoshimura; Hiroki Aoki; Tsutomu Yoshikawa; Yasunori Okada; Ryohei Yozu; Satoshi Ogawa; Keiichi Fukuda
Journal:  Cardiovasc Res       Date:  2011-03-24       Impact factor: 10.787

5.  Elastase-induced experimental aneurysms in rats.

Authors:  S Anidjar; J L Salzmann; D Gentric; P Lagneau; J P Camilleri; J B Michel
Journal:  Circulation       Date:  1990-09       Impact factor: 29.690

6.  Transient exposure to elastase induces mouse aortic wall smooth muscle cell production of MCP-1 and RANTES during development of experimental aortic aneurysm.

Authors:  Jamie S Colonnello; Kirk A Hance; Murray L Shames; Charles W Wyble; Scott J Ziporin; Jeremy E Leidenfrost; Terri L Ennis; Gilbert R Upchurch; Robert W Thompson
Journal:  J Vasc Surg       Date:  2003-07       Impact factor: 4.268

Review 7.  Mouse models of abdominal aortic aneurysms.

Authors:  Alan Daugherty; Lisa A Cassis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-01-22       Impact factor: 8.311

8.  Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability.

Authors:  Pedro R Moreno; K Raman Purushothaman; Valentin Fuster; Dario Echeverri; Helena Truszczynska; Samin K Sharma; Juan J Badimon; William N O'Connor
Journal:  Circulation       Date:  2004-09-27       Impact factor: 29.690

9.  Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat.

Authors:  Jieli Chen; Yi Li; Mark Katakowski; Xiaoguang Chen; Lei Wang; Dunyue Lu; Mei Lu; Subhash C Gautam; Michael Chopp
Journal:  J Neurosci Res       Date:  2003-09-15       Impact factor: 4.164

10.  Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo.

Authors:  A Al-Khaldi; N Eliopoulos; D Martineau; L Lejeune; K Lachapelle; J Galipeau
Journal:  Gene Ther       Date:  2003-04       Impact factor: 5.250

View more
  10 in total

1.  Periadventitial adipose-derived stem cell treatment halts elastase-induced abdominal aortic aneurysm progression.

Authors:  Kory J Blose; Terri L Ennis; Batool Arif; Justin S Weinbaum; John A Curci; David A Vorp
Journal:  Regen Med       Date:  2014       Impact factor: 3.806

Review 2.  Molecular pathogenesis of genetic and sporadic aortic aneurysms and dissections.

Authors:  Ying H Shen; Scott A LeMaire
Journal:  Curr Probl Surg       Date:  2017-02-03       Impact factor: 1.909

Review 3.  Mesenchymal stem cells for treatment of aortic aneurysms.

Authors:  Aika Yamawaki-Ogata; Ryotaro Hashizume; Xian-Ming Fu; Akihiko Usui; Yuji Narita
Journal:  World J Stem Cells       Date:  2014-07-26       Impact factor: 5.326

4.  Mesenchymal Stem Cells Attenuate NADPH Oxidase-Dependent High Mobility Group Box 1 Production and Inhibit Abdominal Aortic Aneurysms.

Authors:  Ashish K Sharma; Morgan D Salmon; Guanyi Lu; Gang Su; Nicolas H Pope; Joseph R Smith; Mark L Weiss; Gilbert R Upchurch
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-03-17       Impact factor: 8.311

5.  Attenuation of aortic aneurysms with stem cells from different genders.

Authors:  John P Davis; Morgan Salmon; Nicolas H Pope; Guanyi Lu; Gang Su; Ashish K Sharma; Gorav Ailawadi; Gilbert R Upchurch
Journal:  J Surg Res       Date:  2015-04-14       Impact factor: 2.192

6.  Perspectives on stem cell-based elastic matrix regenerative therapies for abdominal aortic aneurysms.

Authors:  Chris A Bashur; Raj R Rao; Anand Ramamurthi
Journal:  Stem Cells Transl Med       Date:  2013-05-15       Impact factor: 6.940

7.  Experimental abdominal aortic aneurysm formation is mediated by IL-17 and attenuated by mesenchymal stem cell treatment.

Authors:  Ashish K Sharma; Guanyi Lu; Andrea Jester; William F Johnston; Yunge Zhao; Vanessa A Hajzus; M Reza Saadatzadeh; Gang Su; Castigliano M Bhamidipati; Gaurav S Mehta; Irving L Kron; Victor E Laubach; Michael P Murphy; Gorav Ailawadi; Gilbert R Upchurch
Journal:  Circulation       Date:  2012-09-11       Impact factor: 29.690

8.  Pilot Study of Endovascular Delivery of Mesenchymal Stromal Cells in the Aortic Wall in a Pig Model.

Authors:  Ke Li; Deborah Vela; Elton Migliati; Maria da Graca Cabreira; Xiaohong Wang; L Maximilian Buja; Emerson C Perin
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

9.  Combined administration of mesenchymal stem cells overexpressing IGF-1 and HGF enhances neovascularization but moderately improves cardiac regeneration in a porcine model.

Authors:  Guadalupe Gómez-Mauricio; Isabel Moscoso; María-Fernanda Martín-Cancho; Verónica Crisóstomo; Cristina Prat-Vidal; Claudia Báez-Díaz; Francisco M Sánchez-Margallo; Antonio Bernad
Journal:  Stem Cell Res Ther       Date:  2016-07-16       Impact factor: 6.832

10.  Preservation of Smooth Muscle Cell Integrity and Function: A Target for Limiting Abdominal Aortic Aneurysm Expansion?

Authors:  Emily R Clark; Rebecca J Helliwell; Marc A Bailey; Karen E Hemmings; Katherine I Bridge; Kathryn J Griffin; D Julian A Scott; Louise M Jennings; Kirsten Riches-Suman; Karen E Porter
Journal:  Cells       Date:  2022-03-19       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.